Natural product-based High-Density lipoprotein therapy: Fumigaclavine C increases High-Density lipoprotein levels via up regulation of ABCA1, 5/June/2015, 7.53 am

MiRNA-based Lifespan extension therapy: MiRNA-138 promotes mammalian life span via down regulation of angiotensin II type I receptor (AT1R), 5/June/2014, 7.49 am
June 5, 2015
Natural product-based therapy for Regenerating the lost cardiomyocytes in Myocardial patients: Phlorotannin, isolated from the edible brown alga Ecklonia stolonifera, increases the expression of ERBB2/Her2 and promotes dedifferentiation of cardiomyocytes via down regulation of its target gene, 5/June/2015, 10.23 pm
June 5, 2015
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, L., Natural product-based High-Density lipoprotein therapy: Fumigaclavine C increases High-Density lipoprotein levels via up regulation of ABCA1, 5/June/2015, 7.53 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Significance: 

This suggests, for the first time, that Fumigaclavine C, by increasing the expression of its target gene ABCA1, it may increase the level of High-Density lipoproteins.  Thus, pharmacological formulations encompassing Fumigaclavine C may be used to treat disorders associated with lipid metabolism.

Undisclosed information: How Fumigaclavine C  increases the expression of ABCA1

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Comments are closed.